The expression of calbindin in chicks that are divergently selected for low or high incidence of tibial dyschondroplasia.
Three experiments were conducted with broiler chicks that were divergently selected for low or high incidence of tibial dyschondroplasia (LTD and HTD, respectively) to determine if the expression of intestinal calbindin-28 kD mRNA and protein differed between the 2 strains. In addition, levels of intestinal vitamin D receptor mRNA and plasma thyroid hormone concentrations were also examined. In experiment 1, LTD and HTD chicks were fed a corn-soybean meal diet that was adequate in all nutrients except cholecalciferol (D3), which was titrated to 5 or 40 microg/kg diet in a completely randomized 2 x 2 factorial arrangement. At 4 and 8 d of age, HTD chicks fed 5 microg of D3/kg of diet had a lower (P < 0.05) expression level of calbindin-28 kD mRNA than the LTD chicks fed the same diet. At 4 and 8 d of age, HTD chicks fed 5 microg of D3 had the lowest intestinal expression of calbindin-28 kD protein. Expression of vitamin D receptor mRNA did not differ for broiler strains at either level of D3 supplementation. In experiment 2, there was no significant difference in the expression of calbindin-28 kD mRNA or vitamin D receptor mRNA between day-of-hatch LTD, HTD, and commercial broiler chicks. Experiment 3 was similar in design to the first experiment except that the birds were fed for 18 d. Calbindin-28 kD and vitamin D receptor mRNA expression levels at 18 d were similar to those observed in experiment 1. Plasma triiodothyronine and free-triiodothyronine concentrations were greater for LTD chicks, regardless of dietary D3 supplementation levels. These results suggest that divergent selection of broilers for LTD or HTD alters the physiological response to nutritionally inadequate levels of dietary D3.
Shirley
R B
RB
Department of Poultry Science, The University of Georgia, Athens, Georgia 30602, USA.
Davis
A J
AJ
Compton
M M
MM
Berry
W D
WD
D000818:Animals; D064026:Calbindins; D002645:Chickens / Q000235:genetics*; D002762:Cholecalciferol / Q000008:administration & dosage; D004032:Diet; D015870:Gene Expression / Q000187:drug effects; D020022:Genetic Predisposition to Disease; D007422:Intestines / Q000737:chemistry; D010009:Osteochondrodysplasias / Q000235:genetics / Q000662:veterinary*; D011201:Poultry Diseases / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis; D018167:Receptors, Calcitriol / Q000235:genetics; D064030:S100 Calcium Binding Protein G / Q000235:genetics*; D012641:Selection, Genetic; D013963:Thyroid Hormones / Q000097:blood; D013977:Tibia
D064026:Calbindins; D012333:RNA, Messenger; D018167:Receptors, Calcitriol; D064030:S100 Calcium Binding Protein G; D013963:Thyroid Hormones; D002762:Cholecalciferol